Nucleic acid sensing Toll-like receptors in dendritic cells

Current Opinion in Immunology

Volumn 20, Issue 4, 2008, Pages 408-413

  Hoshino, Katsuaki ^a   Kaisho, Tsuneyasu ^a  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; INTERFERON; INTERFERON REGULATORY FACTOR 7; MYELOID DIFFERENTIATION FACTOR 88; NUCLEIC ACID; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; LUPUS ERYTHEMATOSUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; AUTOIMMUNITY; DENDRITIC CELLS; HUMANS; I-KAPPA B KINASE; INTERFERON TYPE I; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; NUCLEIC ACIDS; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS;

EID: 48549095188     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2008.06.003     Document Type: Review

References (50)

1. Beutler B., Eidenschenk C., Crozat K., Imler J.L., Takeuchi O., Hoffmann J.A., and Akira S. Genetic analysis of resistance to viral infection. Nat Rev Immunol 7 (2007) 753-766
2. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 449 (2007) 819-826
3. Diebold S.S., Kaisho T., Hemmi H., Akira S., and Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004) 1529-1531
4. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., and Bauer S. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303 (2004) 1526-1529
5. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., Horiuchi T., Tomizawa H., Takeda K., and Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3 (2002) 196-200
6. Kariko K., Ni H., Capodici J., Lamphier M., and Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279 (2004) 12542-12550
7. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
8. Haas T., Metzger J., Schmitz F., Heit A., Muller T., Latz E., and Wagner H. The DNA sugar backbone 2' deoxyribose determines Toll-like receptor 9 activation. Immunity 28 (2008) 315-323. This study demonstrates that the phosphodiester 2′ deoxyribose backbone rather than CpG motif is important for TLR9 agonistic activity in the context of natural DNA.
9. Honda K., Takaoka A., and Taniguchi T. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25 (2006) 349-360
10. Baccala R., Hoebe K., Kono D.H., Beutler B., and Theofilopoulos A.N. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 13 (2007) 543-551
11. Banchereau J., and Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25 (2006) 383-392
12. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6 (2006) 823-835
13. Liu Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23 (2005) 275-306
14. Kato H., Sato S., Yoneyama M., Yamamoto M., Uematsu S., Matsui K., Tsujimura T., Takeda K., Fujita T., Takeuchi O., et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23 (2005) 19-28
15. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005) 772-777. This study demonstrates crucial roles of IRF-7 in type I IFN production not only from virus-activated fibroblasts but also from TLR7/9-stimulated pDCs.
16. Hacker H., and Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE 2006 (2006) re13
17. Bonizzi G., and Karin M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25 (2004) 280-288
18. Hoshino K., Sugiyama T., Matsumoto M., Tanaka T., Saito M., Hemmi H., Ohara O., Akira S., and Kaisho T. IκB kinase-α is critical for interferon-α production induced by Toll-like receptors 7 and 9. Nature 440 (2006) 949-953. This study clarifies crucial roles of IKKα in dendritic cells. Through the association with and phosphorylation of IRF-7, IKKα is crucially involved in type I IFN production from TLR7/9-stimulated pDCs.
19. Uematsu S., Sato S., Yamamoto M., Hirotani T., Kato H., Takeshita F., Matsuda M., Coban C., Ishii K.J., Kawai T., et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction. J Exp Med 201 (2005) 915-923
20. Hacker H., Redecke V., Blagoev B., Kratchmarova I., Hsu L.C., Wang G.G., Kamps M.P., Raz E., Wagner H., Hacker G., et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439 (2006) 204-207
21. Oganesyan G., Saha S.K., Guo B., He J.Q., Shahangian A., Zarnegar B., Perry A., and Cheng G. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439 (2006) 208-211
22. Shinohara M.L., Lu L., Bu J., Werneck M.B., Kobayashi K.S., Glimcher L.H., and Cantor H. Osteopontin expression is essential for interferon-α production by plasmacytoid dendritic cells. Nat Immunol 7 (2006) 498-506
23. Guiducci C., Ghirelli C., Marloie-Provost M.A., Matray T., Coffman R.L., Liu Y.J., Barrat F.J., and Soumelis V. PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation. J Exp Med 205 (2008) 315-322
24. Asselin-Paturel C., Brizard G., Chemin K., Boonstra A., O'Garra A., Vicari A., and Trinchieri G. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J Exp Med 201 (2005) 1157-1167
25. Watarai H., Sekine E., Inoue S., Nakagawa R., Kaisho T., and Taniguchi M. PDC-TREM, a plasmacytoid dendritic cell-specific receptor, is responsible for augmented production of type I interferon. Proc Natl Acad Sci U S A 105 (2008) 2993-2998
26. Shortman K., and Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7 (2007) 19-30
27. - dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J Immunol 174 (2005) 6592-6597. This study characterizes murine DC subsets and demonstrates that functional and phenotypic equivalents of splenic DCs can be generated in vitro when BM cells are cultured in the presence of Flt3L.
28. Heath W.R., Belz G.T., Behrens G.M., Smith C.M., Forehan S.P., Parish I.A., Davey G.M., Wilson N.S., Carbone F.R., and Villadangos J.A. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 199 (2004) 9-26
29. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 195 (2002) 1289-1302
30. Dudziak D., Kamphorst A.O., Heidkamp G.F., Buchholz V.R., Trumpfheller C., Yamazaki S., Cheong C., Liu K., Lee H.W., Park C.G., et al. Differential antigen processing by dendritic cell subsets in vivo. Science 315 (2007) 107-111
31. + DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 33 (2003) 827-833
32. + DC is activated to exhibit crosspriming activity through TLR3 signaling.
33. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 (2006) 101-105
34. Sugiyama T., Hoshino K., Saito M., Yano T., Sasaki I., Yamazaki C., Akira S., and Kaisho T. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7. Int Immunol 20 (2008) 1-9
35. Kagan J.C., Su T., Horng T., Chow A., Akira S., and Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nat Immunol 9 (2008) 361-368
36. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., Lien E., Nilsen N.J., Espevik T., and Golenbock D.T. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 5 (2004) 190-198
37. Barton G.M., Kagan J.C., and Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self-DNA but facilitates access to viral DNA. Nat Immunol 7 (2006) 49-56
38. Means T.K., Latz E., Hayashi F., Murali M.R., Golenbock D.T., and Luster A.D. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 115 (2005) 407-417. This study clarifies the mechanisms by which the DNA-containing ICs activate pDC to produce type I IFNs.
39. •,40] show that self-DNAs can function as potent TLR9 agonists through the association with the endogenous molecules such as an antimicrobial peptide or a nuclear DNA-binding protein.
40. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8 (2007) 487-496
41. Jego G., Palucka A.K., Blanck J.P., Chalouni C., Pascual V., and Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19 (2003) 225-234
42. Curtsinger J.M., Valenzuela J.O., Agarwal P., Lins D., and Mescher M.F. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol 174 (2005) 4465-4469
43. Izui S., Iwamoto M., Fossati L., Merino R., Takahashi S., and Ibnou-Zekri N. The Yaa gene model of systemic lupus erythematosus. Immunol Rev 144 (1995) 137-156
44. •,45] suggest that TLR7 gene duplication is the basis for manifestations of murine autoimmune-prone BXSB mice.
45. Subramanian S., Tus K., Li Q.Z., Wang A., Tian X.H., Zhou J., Liang C., Bartov G., McDaniel L.D., Zhou X.J., et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci U S A 103 (2006) 9970-9975
46. Deane J.A., Pisitkun P., Barrett R.S., Feigenbaum L., Town T., Ward J.M., Flavell R.A., and Bolland S. Control of Toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27 (2007) 801-810
47. lpr/lpr.
48. Asagiri M., Hirai T., Kunigami T., Kamano S., Gober H.J., Okamoto K., Nishikawa K., Latz E., Golenbock D.T., Aoki K., et al. Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis. Science 319 (2008) 624-627
49. Matsumoto F., Saitoh S., Fukui R., Kobayashi T., Tanimura N., Konno K., Kusumoto Y., Akashi-Takamura S., and Miyake K. Cathepsins are required for Toll-like receptor 9 responses. Biochem Biophys Res Commun 367 (2008) 693-699
50. Gorden K.B., Gorski K.S., Gibson S.J., Kedl R.M., Kieper W.C., Qiu X., Tomai M.A., Alkan S.S., and Vasilakos J.P. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 174 (2005) 1259-1268